Cardiol Therapeutics Statistics

Total Valuation

Cardiol Therapeutics has a market cap or net worth of CAD 152.60 million. The enterprise value is 136.88 million.

Market Cap	152.60M
Enterprise Value	136.88M

Important Dates

The next estimated earnings date is Friday, March 28, 2025.

Earnings Date	Mar 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Cardiol Therapeutics has 81.60 million shares outstanding. The number of shares has increased by 5.66% in one year.

Current Share Class	n/a
Shares Outstanding	81.60M
Shares Change (YoY)	+5.66%
Shares Change (QoQ)	+1.59%
Owned by Insiders (%)	4.67%
Owned by Institutions (%)	6.26%
Float	77.78M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	12.58
P/TBV Ratio	14.63
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-3.79
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-5.27

Financial Position

The company has a current ratio of 2.49, with a Debt / Equity ratio of 0.02.

Current Ratio	2.49
Quick Ratio	2.32
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	-0.01
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -159.53% and return on invested capital (ROIC) is -104.92%.

Return on Equity (ROE)	-159.53%
Return on Assets (ROA)	-79.07%
Return on Capital (ROIC)	-104.92%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +59.83% in the last 52 weeks. The beta is 0.70, so Cardiol Therapeutics's price volatility has been lower than the market average.

Beta (5Y)	0.70
52-Week Price Change	+59.83%
50-Day Moving Average	2.37
200-Day Moving Average	2.68
Relative Strength Index (RSI)	29.73
Average Volume (20 Days)	89,071

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-38.32M
Pretax Income	-36.14M
Net Income	-36.14M
EBITDA	-38.17M
EBIT	-38.32M
Earnings Per Share (EPS)	-0.53

Full Income Statement

Balance Sheet

The company has 15.89 million in cash and 165,984 in debt, giving a net cash position of 15.72 million or 0.19 per share.

Cash & Cash Equivalents	15.89M
Total Debt	165,984
Net Cash	15.72M
Net Cash Per Share	0.19
Equity (Book Value)	10.43M
Book Value Per Share	0.15
Working Capital	10.33M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -25.93 million and capital expenditures -25,837, giving a free cash flow of -25.96 million.

Operating Cash Flow	-25.93M
Capital Expenditures	-25,837
Free Cash Flow	-25.96M
FCF Per Share	-0.32

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Cardiol Therapeutics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5.66%
Shareholder Yield	-5.66%
Earnings Yield	-28.52%
FCF Yield	-17.01%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a